Education
About Us
Working with TipRanks
Follow Us
GVLE - ETF AI Analysis
Top Page
Goldman Sachs Value Opportunities ETF (GVLE)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Top Holdings
The ETF includes well-established companies like Morgan Stanley, JPMorgan Chase, and Walmart, which have shown steady performance and contribute to the fund's stability.
Sector Diversification
The fund is spread across multiple sectors, including Financials, Industrials, and Health Care, reducing the risk of overexposure to any single industry.
Moderate Expense Ratio
The ETF's expense ratio is reasonable compared to many actively managed funds, helping investors retain more of their returns.
Negative Factors
High Geographic Concentration
The ETF is heavily concentrated in U.S. companies, offering limited exposure to international markets and global diversification.
Financial Sector Overweight
Nearly a quarter of the portfolio is allocated to the Financial sector, increasing vulnerability to downturns in that industry.
Modest Recent Performance
The fund's recent performance has been positive but relatively modest, which may not appeal to investors seeking higher growth potential.
GVLE vs. SPDR S&P 500 ETF (SPY)
AUM43.98M
RegionNorth America
Expense Ratio0.45%
Beta0.82
IssuerGoldman Sachs
Inception DateNov 17, 2025
Dividend Yield1.14%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,474
30 Day Avg. Volume2,881
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.85Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering35
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GVLE Summary
The Goldman Sachs Value Opportunities ETF (GVLE) is a fund that focuses on investing in undervalued companies across the entire U.S. stock market. It aims to find stocks that are trading below their true worth, offering potential for long-term growth. The ETF includes well-known companies like JPMorgan Chase and Walmart, along with others from sectors such as financials, healthcare, and technology. This ETF could be a good choice for investors looking to diversify their portfolio with value-oriented stocks. However, new investors should know that the fund’s performance depends on the market recognizing the value of these stocks, which can take time and may involve market fluctuations.
How much will it cost me?The Goldman Sachs Value Opportunities ETF (GVLE) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, with experts carefully selecting undervalued stocks to maximize potential returns.
What would affect this ETF?The GVLE ETF, with its focus on undervalued U.S. companies across various sectors, could benefit from a strong economic recovery or increased investor interest in value stocks, particularly in sectors like financials and healthcare, which are heavily weighted in the fund. However, it may face challenges if interest rates rise, as this could negatively impact financial stocks, or if economic uncertainty leads to reduced consumer spending, affecting cyclical sectors like consumer discretionary. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings, such as Morgan Stanley and JPMorgan Chase.
GVLE Top 10 Holdings
The Goldman Sachs Value Opportunities ETF (GVLE) leans heavily on financials, with Morgan Stanley, JPMorgan Chase, and Bank of America among its top holdings, all showing steady to rising performance thanks to strong earnings and positive sentiment. Capital One Financial has been a standout, with robust growth fueled by strategic acquisitions, giving the fund a boost. However, the fund’s exposure to consumer defensive names like Walmart, which is steady but not offering immediate value, and healthcare stocks like Abbott Laboratories, which has faced recent headwinds, has tempered gains. With its U.S.-focused, value-driven strategy, GVLE is banking on undervalued opportunities to deliver long-term growth.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Morgan Stanley | 4.95% | $2.18M | $293.51B | 49.60% | 76 Outperform | |
| Capital One Financial | 4.93% | $2.17M | $158.42B | 45.86% | 71 Outperform | |
| JPMorgan Chase | 4.86% | $2.14M | $896.14B | 37.49% | 72 Outperform | |
| Bank of America | 4.80% | $2.11M | $410.25B | 24.54% | 72 Outperform | |
| Amazon | 4.17% | $1.84M | $2.63T | 12.49% | 71 Outperform | |
| Walmart | 4.15% | $1.83M | $901.19B | 21.58% | 78 Outperform | |
| Thermo Fisher | 3.91% | $1.72M | $227.87B | 11.84% | 72 Outperform | |
| Ameren | 3.71% | $1.63M | $26.93B | 13.06% | 72 Outperform | |
| Honeywell International | 3.65% | $1.61M | $130.30B | -5.94% | 77 Outperform | |
| Abbott Laboratories | 3.54% | $1.56M | $218.96B | 12.35% | 73 Outperform |
GVLE Technical Analysis
Positive
―
Price Trends
Market Momentum
0.48
Negative
66.31
Neutral
79.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GVLE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 40.95, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.48 indicates Negative momentum. The RSI at 66.31 is Neutral, neither overbought nor oversold. The STOCH value of 79.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GVLE.
GVLE Peer Comparison
Comparison Results
Performance Comparison
GVLE
Goldman Sachs Value Opportunities ETF
41.72
2.84
7.30%
BAMV
Brookstone Value Stock ETF
―
―
―
TCV
Towle Value ETF
―
―
―
GMOV
GMO US Value ETF
―
―
―
VUSV
Vanguard Wellington U.S. Value Active ETF
―
―
―
CVAR
Cultivar ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents